Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant

Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.

Theradaptive's OsteoAdapt
• Source: OsteoAdapt

More from Regulation

More from Policy & Regulation